Eric Jonasch Selected Research

Cytoreduction Surgical Procedures

7/2012	Rapid angiogenesis onset after discontinuation of sunitinib treatment of renal cell carcinoma patients.
11/2011	Safety of presurgical targeted therapy in the setting of metastatic renal cell carcinoma.
11/2007	Cytoreductive nephrectomy for metastatic renal cell carcinoma with nonclear cell histology.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Eric Jonasch Research Topics

Disease

141	Renal Cell Carcinoma (Grawitz Tumor) 02/2024 - 11/2003
74	Neoplasms (Cancer) 04/2024 - 11/2003
19	Neoplasm Metastasis (Metastasis) 12/2021 - 03/2005
17	Kidney Neoplasms (Kidney Cancer) 01/2024 - 10/2008
12	Disease Progression 11/2023 - 05/2006
11	Hypoxia (Hypoxemia) 11/2021 - 05/2009
10	von Hippel-Lindau Disease (von Hippel Lindau Disease) 02/2024 - 02/2009
7	Fatigue 12/2019 - 01/2009
5	Carcinogenesis 11/2023 - 06/2014
4	Carcinoma (Carcinomatosis) 01/2022 - 06/2014
3	Hemangioblastoma 11/2021 - 06/2012
3	Pheochromocytoma 10/2018 - 07/2008
3	Diarrhea 01/2018 - 01/2009
3	Nausea 09/2017 - 09/2011
3	Breast Neoplasms (Breast Cancer) 08/2017 - 11/2003
3	Hypertension (High Blood Pressure) 10/2015 - 11/2013
2	Neuroendocrine Tumors (Neuroendocrine Tumor) 02/2024 - 05/2021
2	Serous Cystadenoma 02/2024 - 10/2018
2	Brain Neoplasms (Brain Tumor) 10/2023 - 12/2013
2	Aneuploidy (Aneuploid) 01/2023 - 10/2017
2	Medullary Carcinoma 01/2023 - 04/2021
2	Exanthema (Rash) 04/2021 - 01/2009
2	Hand-Foot Syndrome 01/2018 - 10/2014
2	Vomiting 09/2017 - 08/2014
2	Pneumonia (Pneumonitis) 10/2014 - 03/2014
2	Wounds and Injuries (Trauma) 11/2011 - 09/2009
1	Primitive Neuroectodermal Tumors (PNET) 02/2024
1	Ataxia Telangiectasia (Louis Bar Syndrome) 10/2023
1	Trisomy (Trisomies) 01/2023
1	Chromosomal Instability (Chromosome Stability) 01/2023
1	Rare Diseases (Rare Disease) 10/2022
1	Microsatellite Instability 04/2022
1	Osteonecrosis (Kienbock's Disease) 01/2022
1	Dizziness (Lightheadedness) 11/2021

Drug/Important Bio-Agent (IBA)

20	Biomarkers (Surrogate Marker)IBA 01/2023 - 05/2009
17	Sunitinib (Sutent)FDA Link 01/2023 - 07/2008
17	Tyrosine Kinase InhibitorsIBA 01/2022 - 02/2009
14	Proteins (Proteins, Gene)FDA Link 10/2023 - 07/2008
14	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2023 - 02/2009
11	pazopanib FDA Link 01/2019 - 06/2012
10	Immune Checkpoint InhibitorsIBA 10/2023 - 01/2020
10	Bevacizumab (Avastin)FDA Link 01/2023 - 07/2008
10	Everolimus FDA Link 09/2021 - 10/2014
10	Axitinib (AG 013736)IBA 01/2020 - 11/2011
8	belzutifanIBA 02/2024 - 01/2021
8	Sorafenib (BAY 43-9006)FDA Link 01/2019 - 07/2008
8	TOR Serine-Threonine KinasesIBA 01/2016 - 08/2013
7	CytokinesIBA 01/2023 - 05/2008
7	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2022 - 10/2015
6	DNA (Deoxyribonucleic Acid)IBA 10/2023 - 01/2015
6	Gemcitabine FDA Link 08/2017 - 05/2006
5	Transcription Factors (Transcription Factor)IBA 11/2023 - 11/2010
5	Capecitabine (Xeloda)FDA Link 08/2017 - 05/2006
4	Indicators and Reagents (Reagents)IBA 10/2023 - 10/2015
4	RNA (Ribonucleic Acid)IBA 01/2021 - 05/2013
3	NivolumabIBA 01/2022 - 09/2018
3	cabozantinibIBA 09/2021 - 09/2020
3	Oxygen (Dioxygen)IBA 01/2019 - 06/2014
3	Protein Isoforms (Isoforms)IBA 07/2018 - 11/2011
3	ChromatinIBA 10/2017 - 02/2014
3	MTOR InhibitorsIBA 11/2014 - 08/2013
2	GlycosaminoglycansIBA 01/2023 - 12/2022
2	InterferonsIBA 01/2023 - 05/2009
2	endothelial PAS domain-containing protein 1IBA 04/2022 - 05/2021
2	Retinaldehyde (Retinal)IBA 11/2021 - 10/2018
2	EnzymesIBA 01/2019 - 08/2004
2	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2018 - 01/2015
2	MethyltransferasesIBA 08/2016 - 02/2014
2	Histones (Histone)IBA 08/2016 - 01/2016
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 06/2012 - 02/2009
2	Zoledronic Acid (Zometa)FDA Link 12/2011 - 08/2006
2	Interferon-alpha (Interferon Alfa)IBA 01/2010 - 11/2006
2	Thalidomide (Thalomid)FDA Link 02/2009 - 08/2006
1	Glucose (Dextrose)FDA LinkGeneric 04/2024
1	Chemokine CX3CL1IBA 04/2024
1	Interferon Receptors (Interferon Receptor)IBA 01/2023
1	MicroRNAs (MicroRNA)IBA 01/2023
1	PlatinumIBA 01/2023
1	Glycoproteins (Glycoprotein)IBA 01/2023
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2023
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 04/2022
1	AntibodiesIBA 01/2022
1	sitravatinibIBA 01/2022
1	Fentanyl (Sublimaze)FDA LinkGeneric 11/2021
1	tremelimumabIBA 11/2021
1	Checkpoint Kinase 1IBA 10/2021

Therapy/Procedure

94	Therapeutics 04/2024 - 08/2004
29	Nephrectomy 01/2023 - 03/2005
9	Immunotherapy 10/2023 - 01/2007
4	Drug Therapy (Chemotherapy) 01/2023 - 01/2007
4	Radiotherapy 01/2022 - 08/2006
3	Molecular Targeted Therapy 12/2021 - 07/2008
3	Metastasectomy 09/2016 - 08/2009
3	Neoadjuvant Therapy 06/2014 - 09/2008
3	Cytoreduction Surgical Procedures 07/2012 - 11/2007
2	Aftercare (After-Treatment) 05/2013 - 02/2011
2	Radiofrequency Ablation 11/2010 - 05/2005
1	Contraindications 01/2022
1	Nephroureterectomy 01/2022
1	Cryosurgery 11/2021